Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Information procurement
1.2.1. Purchased database
1.2.2. GVR’s internal database
1.2.3. Secondary sources & third party perspectives
1.2.4. Primary research
1.3. Information analysis
1.3.1. Data analysis models
1.4. Market formulation & data visualization
1.5. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Cellulite Treatment Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis
3.4. User perspective analysis
3.4.1. Consumer Behavior Analysis
3.4.2. Market Influencer Analysis
3.5. Regulatory Framework
3.5.1. Reimbursement framework
3.5.2. Standards & Compliances
3.6. Market Dynamics
3.6.1. Market Driver Analysis
3.6.1.1. Growing prevalence of obesity
3.6.2. Market Restraint Analysis
3.6.2.1. High Cost
3.6.3. Industry Challenges
3.7. Cellulite Treatment: Market Analysis Tools
3.7.1. Industry Analysis – Porter’s
3.7.1.1. Supplier Power
3.7.1.2. Buyer Power
3.7.1.3. Substitution Threat
3.7.1.4. Threat from new entrant
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political Landscape
3.7.2.2. Environmental Landscape
3.7.2.3. Social Landscape
3.7.2.4. Technology Landscape
3.7.2.5. Legal Landscape
3.7.3. Major Deals & Strategic Alliances Analysis
3.7.3.1. Joint Ventures
3.7.3.2. Mergers & Acquisitions
3.7.3.3. Licensing & Partnership
3.7.3.4. Technology Collaborations
3.7.3.5. Strategic Divestments
3.7.3.6. Market Entry Strategies
Chapter 4. Cellulite Treatment Market: Segment Analysis, By Procedure Type, 2018 – 2030 (USD Million)
4.1. Definitions & Scope
4.2. Procedure type market share analysis, 2021 & 2030
4.3. Segment Dashboard
4.4. Global Cellulite Treatment Market, By Procedure Type, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Non-invasive
4.5.2. Minimally invasive
4.5.3. Topical
Chapter 5. Cellulite Treatment Market: Segment Analysis, By Cellulite Type, 2018 – 2030 (USD Million)
5.1. Definitions & Scope
5.2. Cellulite type market share analysis, 2021 & 2030
5.3. Segment Dashboard
5.4. Global Cellulite Treatment Market, By Cellulite Type, 2018 to 2030
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Soft cellulite
5.5.2. Hard cellulite
5.5.3. Edematous Cellulite
Chapter 6. Cellulite Treatment Market: Segment Analysis, By End-use, 2018 – 2030 (USD Million)
6.1. Definitions & Scope
6.2. End-use market share analysis, 2021 & 2030
6.3. Segment Dashboard
6.4. Global Cellulite Treatment Market, By End-use, 2018 to 2030
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.2. Clinics & Beauty Centers
Chapter 7. Cellulite Treatment Market: Regional Market Analysis, By Region, 2018 – 2030 (USD Million)
7.1. Definitions & Scope
7.2. Regional market share analysis, 2021 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.5. Regional Market Share and Leading Players, 2021
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East & Africa
7.6. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.6.1. North America
7.6.2. Europe
7.6.3. Asia Pacific
7.6.4. Latin America
7.6.5. Middle East & Africa
7.7. Market Size, & Forecasts, and Trend Analysis, 2022 to 2030:
7.8. North America
7.8.1.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
7.8.1.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.8.1.3. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.8.1.4. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.8.2. U.S.
7.8.2.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.8.2.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.8.2.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.8.3. Canada
7.8.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.8.3.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.8.3.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.9. Europe
7.9.1.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
7.9.1.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.9.1.3. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.9.1.4. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.9.2. Germany
7.9.2.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.9.2.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.9.2.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.9.3. U.K.
7.9.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.9.3.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.9.3.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.9.4. France
7.9.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.9.4.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.9.4.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.9.5. Italy
7.9.5.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.9.5.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.9.5.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.9.6. Spain
7.9.6.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.9.6.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.9.6.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.10. Asia Pacific
7.10.1.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
7.10.1.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.10.1.3. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.10.1.4. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.10.2. China
7.10.2.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.10.2.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.10.2.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.10.3. Japan
7.10.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.10.3.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.10.3.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.10.4. India
7.10.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.10.4.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.10.4.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.10.5. Thailand
7.10.5.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.10.5.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.10.5.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.10.6. South Korea
7.10.6.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.10.6.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.10.6.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.10.7. Australia
7.10.7.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.10.7.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.10.7.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.11. Latin America
7.11.1.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
7.11.1.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.11.1.3. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.11.1.4. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.11.2. Brazil
7.11.2.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.11.2.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.11.2.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.11.3. Mexico
7.11.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.11.3.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.11.3.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.11.4. Argentina
7.11.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.11.4.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.11.4.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.12. Middle East and Africa
7.12.1.1. Market estimates and forecast, by country, 2018 – 2030 (USD Million)
7.12.1.2. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.12.1.3. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.12.1.4. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.12.2. South Africa
7.12.2.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.12.2.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.12.2.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.12.3. Saudi Arabia
7.12.3.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.12.3.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.12.3.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
7.12.4. UAE
7.12.4.1. Market estimates and forecast, by procedure type, 2018 – 2030 (USD Million)
7.12.4.2. Market estimates and forecast, by cellulite type, 2018 – 2030 (USD Million)
7.12.4.3. Market estimates and forecast, by end-use, 2018 – 2030 (USD Million)
Chapter 8. Cellulite Treatment Market – Competitive Analysis
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2021
8.3.4. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.4. Supplier Ranking
8.5. Key companies profiled
8.5.1. Merz Pharma.
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Hologic, Inc. (Cynosure)
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Syneron Medical
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Zimmer Aesthetics.
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Tanceuticals, LLC
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Cymedics.
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Nubway
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives